CellCentric Ltd.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma (NCT07096778) | CellCentric Ltd. | 2026-01-22 |
| Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies (NCT04068597) | CellCentric Ltd. | 2019-08-09 |
| Study to Evaluate CCS1477 in Advanced Tumours (NCT03568656) | CellCentric Ltd. | 2018-07-23 |
Track CellCentric Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.